Sagun Agrawal1, Alexis C Wojtanowski2, Laura Tringali2, Gary D Foster2,3, Eric A Finkelstein1. 1. Program in Health Services & Systems Research, Duke-NUS Medical School, Singapore, Singapore. 2. WW International (formerly Weight Watchers), New York, NY, United States of America. 3. Center for Weight and Eating Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA, United States of America.
Abstract
PURPOSE: To estimate potential annual savings in medical expenditures from a subsidized weight management program from the NYC Government perspective. DESIGN: Longitudinal observational study. SETTING: Employees of New York City (NYC) government and enrolled dependents. SAMPLE: 14,946 participants with overweight and obesity. INTERVENTION: WW (formerly Weight Watchers®) 'Workshop' and 'Digital' programs. MEASURES: Participation rate, enrollment duration, weight change, and predicted gross and net total and per capita medical expenditure savings and return on investment (ROI). ANALYSIS: Participation rate, enrollment duration, weight change, and program costs are based on direct observation. Predicted savings are simulated based on published data relating weight loss to medical expenditure reductions. RESULTS: In total, 47% of participating employees and 50% of participating dependents lost weight during the enrollment period. Mean (median) enrollment duration for employees was 7.1 months (7.0) and for dependents was 6.9 months (6.0). Mean (median) weight losses for the employees in 'Workshops' and 'Digital' was 6.6 lbs (2.80) and 6.3 lbs (0.0). For dependents, weight losses were 7.4 lbs (3.59) and 11.6 lbs (2.0). Per capita and total predicted net savings to NYC Government from employees was estimated to be $120 and $1,486,102 for an ROI of 143%. Including dependents, predicted net savings increases to $1,963,431 for an ROI of 189%. Over 80% of savings came from participants in the Obese III category. CONCLUSION: An evidence-based weight management program has the potential to generate a positive ROI for employers. Future studies should validate these estimates using actual data and more rigorous designs.
PURPOSE: To estimate potential annual savings in medical expenditures from a subsidized weight management program from the NYC Government perspective. DESIGN: Longitudinal observational study. SETTING: Employees of New York City (NYC) government and enrolled dependents. SAMPLE: 14,946 participants with overweight and obesity. INTERVENTION: WW (formerly Weight Watchers®) 'Workshop' and 'Digital' programs. MEASURES: Participation rate, enrollment duration, weight change, and predicted gross and net total and per capita medical expenditure savings and return on investment (ROI). ANALYSIS: Participation rate, enrollment duration, weight change, and program costs are based on direct observation. Predicted savings are simulated based on published data relating weight loss to medical expenditure reductions. RESULTS: In total, 47% of participating employees and 50% of participating dependents lost weight during the enrollment period. Mean (median) enrollment duration for employees was 7.1 months (7.0) and for dependents was 6.9 months (6.0). Mean (median) weight losses for the employees in 'Workshops' and 'Digital' was 6.6 lbs (2.80) and 6.3 lbs (0.0). For dependents, weight losses were 7.4 lbs (3.59) and 11.6 lbs (2.0). Per capita and total predicted net savings to NYC Government from employees was estimated to be $120 and $1,486,102 for an ROI of 143%. Including dependents, predicted net savings increases to $1,963,431 for an ROI of 189%. Over 80% of savings came from participants in the Obese III category. CONCLUSION: An evidence-based weight management program has the potential to generate a positive ROI for employers. Future studies should validate these estimates using actual data and more rigorous designs.
Authors: Faidon Magkos; Gemma Fraterrigo; Jun Yoshino; Courtney Luecking; Kyleigh Kirbach; Shannon C Kelly; Lisa de Las Fuentes; Songbing He; Adewole L Okunade; Bruce W Patterson; Samuel Klein Journal: Cell Metab Date: 2016-02-22 Impact factor: 27.287
Authors: Diana M Thomas; Nicholas Clark; Dusty Turner; Cynthia Siu; Tanya M Halliday; Bridget A Hannon; Chanaka N Kahathuduwa; Cynthia M Kroeger; Roger Zoh; David B Allison Journal: Am J Clin Nutr Date: 2020-02-01 Impact factor: 7.045
Authors: Eric A Finkelstein; Marco daCosta DiBonaventura; Somali M Burgess; Brent C Hale Journal: J Occup Environ Med Date: 2010-10 Impact factor: 2.162
Authors: Craig A Johnston; Stephanie Rost; Karen Miller-Kovach; Jennette P Moreno; John P Foreyt Journal: Am J Med Date: 2013-10-15 Impact factor: 4.965
Authors: Susan A Jebb; Amy L Ahern; Ashley D Olson; Louise M Aston; Christina Holzapfel; Julia Stoll; Ulrike Amann-Gassner; Annie E Simpson; Nicholas R Fuller; Suzanne Pearson; Namson S Lau; Adrian P Mander; Hans Hauner; Ian D Caterson Journal: Lancet Date: 2011-09-07 Impact factor: 79.321
Authors: J G Thomas; H A Raynor; D S Bond; A K Luke; C C Cardoso; A C Wojtanowski; S Vander Veur; D Tate; R R Wing; G D Foster Journal: Obes Sci Pract Date: 2017-10-13